(Q36192787)

English

Pegaptanib: the first antiangiogenic agent approved for neovascular macular degeneration

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12 August 2017

1 reference

Europe PubMed Central

title

Pegaptanib: the first antiangiogenic agent approved for neovascular macular degeneration (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16013991

retrieved

12 August 2017

main subject

angiogenesis inhibitor

1 reference

Sheila A Doggrell

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16013991

retrieved

12 August 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16013991

retrieved

12 August 2017

published in

Expert Opinion on Pharmacotherapy

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16013991

retrieved

12 August 2017

volume

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16013991

retrieved

12 August 2017

issue

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16013991

retrieved

12 August 2017

page(s)

1421-1423

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16013991

retrieved

12 August 2017

cites work

Inhibitors of ocular neovascularization: promises and potential problems.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.6.8.1421

retrieved

21 January 2018

2'-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.6.8.1421

retrieved

21 January 2018

Identifiers

DOI

10.1517/14656566.6.8.1421

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16013991

retrieved

12 August 2017

PubMed publication ID

16013991

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16013991

retrieved

12 August 2017

(Q36192787)

Pegaptanib: the first antiangiogenic agent approved for neovascular macular degeneration

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)